Retatrutide

Triple agonist peptide targeting the GLP-1, GIP and Glucagon receptors.

Classification

Triple incretin and glucagon receptor agonist peptide. Retatrutide belongs to a novel class of metabolic peptides engineered to simultaneously activate GLP-1, GIP, and glucagon receptors. Unlike single- or dual-receptor agonists, Retatrutide is designed to engage multiple complementary pathways involved in appetite regulation, nutrient utilization, energy expenditure, and metabolic function through a single molecule.

Target Receptors

• GLP-1 Receptor – Involved in appetite regulation, satiety signaling, and gastric emptying.
• GIP Receptor – Influences nutrient utilization, metabolic signaling, and energy balance.
• Glucagon Receptor – Associated with energy expenditure, lipid metabolism, and glucose regulation.

Structure

Retatrutide is a synthetic peptide engineered to bind and activate all three receptors simultaneously. Structural modifications increase stability, enhance receptor affinity, and extend its duration of activity, allowing for prolonged engagement of metabolic signaling pathways.

Research Focus

Studied for its potential effects on appetite regulation, body weight reduction, energy expenditure, metabolic flexibility, and overall metabolic function. Its triple-receptor mechanism has made it a significant area of interest within obesity and metabolic research.